Clinical Trial Update: Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hyperpolarized carbon-13 pyruvate MR imaging in humans. The study is currently recruiting to explore imaging in heart failure,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure
• Metabolic Syndrome

Snippet

Sponsor: National Heart Centre Singapore | Conditions: Heart Failure, Cardiometabolic Syndrome | Phase 2 | Status: RECRUITING